{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:52:27Z","timestamp":1781747547667,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["24ZR1412400"],"award-info":[{"award-number":["24ZR1412400"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403063"],"award-info":[{"award-number":["82403063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82090054"],"award-info":[{"award-number":["82090054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13592-4","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T11:24:57Z","timestamp":1738581897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ACSL4 promotes the formation of the proliferative subtype in hepatoblastoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Wei","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"issue":"1","key":"13592_CR1","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1038\/s41467-021-25430-9","volume":"12","author":"G NAGAE","year":"2021","unstructured":"NAGAE G, YAMAMOTO S. Genetic and epigenetic basis of hepatoblastoma diversity[J]. Nat Commun. 2021;12(1):5423.","journal-title":"Nat Commun"},{"issue":"1","key":"13592_CR2","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1038\/s41467-022-32473-z","volume":"13","author":"H SONG","year":"2022","unstructured":"SONG H, BUCHER S, ROSENBERG K, et al. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids[J]. Nat Commun. 2022;13(1):4878.","journal-title":"Nat Commun"},{"issue":"10","key":"13592_CR3","doi-asserted-by":"publisher","first-page":"e1912676","DOI":"10.1001\/jamanetworkopen.2019.12676","volume":"2","author":"J FENG","year":"2019","unstructured":"FENG J, HE Y, WEI L, et al. Assessment of Survival of Pediatric patients with Hepatoblastoma who received Chemotherapy following liver transplant or liver Resection[J]. JAMA Netw Open. 2019;2(10):e1912676.","journal-title":"JAMA Netw Open"},{"key":"13592_CR4","doi-asserted-by":"crossref","unstructured":"WANG JZ, ZHU H, YOU P et al. Upregulated YB-1 protein promotes glioblastoma growth through a YB-1\/CCT4\/mLST8\/mTOR pathway[J]. J Clin Invest, 2022;132(8).","DOI":"10.1172\/JCI146536"},{"issue":"1","key":"13592_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL MEYERS","year":"2017","unstructured":"MEYERS RL, MAIBACH R. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children\u2019s hepatic tumors international Collaboration[J]. Lancet Oncol. 2017;18(1):122\u201331.","journal-title":"Lancet Oncol"},{"issue":"1","key":"13592_CR6","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1038\/s41467-023-39717-6","volume":"14","author":"J FANG","year":"2023","unstructured":"FANG J, SINGH S, CHENG C, et al. Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma[J]. Nat Commun. 2023;14(1):4003.","journal-title":"Nat Commun"},{"key":"13592_CR7","doi-asserted-by":"crossref","unstructured":"CLAVER\u00edA-CABELLO A, HERRANZ J M, LATASA M U, et al. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma[J]. J Hepatol. 2023;79(4):989\u20131005.","DOI":"10.1016\/j.jhep.2023.05.031"},{"key":"13592_CR8","doi-asserted-by":"crossref","unstructured":"ESPINOZA A F, PATEL R H, PATEL K R, et al. A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma[J]. J Hepatol. 2024;80(4):610\u201321.","DOI":"10.1016\/j.jhep.2024.01.003"},{"issue":"1","key":"13592_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/HEP.0000000000000601","volume":"80","author":"M FAILLI","year":"2024","unstructured":"FAILLI M, R\u00edO-\u00c1LVAREZ DEMIRSDEL. Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response[J]. Hepatology. 2024;80(1):55\u201368.","journal-title":"Hepatology"},{"issue":"1","key":"13592_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/hep.29672","volume":"68","author":"J HOOKS K B, AUDOUX","year":"2018","unstructured":"HOOKS K B, AUDOUX J, FAZLI H, et al. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma[J]. Hepatology. 2018;68(1):89\u2013102.","journal-title":"Hepatology"},{"issue":"2","key":"13592_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jhep.2020.03.025","volume":"73","author":"J CARRILLO-REIXACH","year":"2020","unstructured":"CARRILLO-REIXACH J, TORRENS L, SIMON-COMA M, et al. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications[J]. J Hepatol. 2020;73(2):328\u201341.","journal-title":"J Hepatol"},{"issue":"6","key":"13592_CR12","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/hep.32775","volume":"77","author":"H HUANG","year":"2023","unstructured":"HUANG H, WU L, LU L, et al. Single-cell transcriptomics uncovers cellular architecture and developmental trajectories in hepatoblastoma[J]. Hepatology. 2023;77(6):1911\u201328.","journal-title":"Hepatology"},{"issue":"1","key":"13592_CR13","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1038\/s41467-024-47280-x","volume":"15","author":"A ROEHRIG","year":"2024","unstructured":"ROEHRIG A, HIRSCH T Z PIREA, et al. Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma[J]. Nat Commun. 2024;15(1):3031.","journal-title":"Nat Commun"},{"key":"13592_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2015.04.001","volume":"59","author":"D NEESS","year":"2015","unstructured":"NEESS D, BEK S, ENGELSBY H, et al. Long-chain acyl-CoA esters in metabolism and signaling: role of acyl-CoA binding proteins[J]. Prog Lipid Res. 2015;59:1\u201325.","journal-title":"Prog Lipid Res"},{"issue":"14","key":"13592_CR15","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"STOCKWELL B R","year":"2022","unstructured":"STOCKWELL B R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications[J]. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"key":"13592_CR16","doi-asserted-by":"crossref","unstructured":"LIAO P, WANG W, WANG W et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4[J]. Cancer Cell, 2022;40(4):365\u2013\u200978.e6.","DOI":"10.1016\/j.ccell.2022.02.003"},{"issue":"1","key":"13592_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/hep.32148","volume":"75","author":"J DUAN","year":"2022","unstructured":"DUAN J, WANG Z, DUAN R, et al. Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice[J]. Hepatology. 2022;75(1):140\u201353.","journal-title":"Hepatology"},{"issue":"6","key":"13592_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/cr.2011.2","volume":"21","author":"S PAZ","year":"2011","unstructured":"PAZ S, VILASCO M, WERDEN SJ, et al. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response[J]. Cell Res. 2011;21(6):895\u2013910.","journal-title":"Cell Res"},{"issue":"5","key":"13592_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.immuni.2016.04.009","volume":"44","author":"S CHATTOPADHYAY","year":"2016","unstructured":"CHATTOPADHYAY S, KUZMANOVIC T, ZHANG Y, et al. Ubiquitination of the transcription factor IRF-3 activates RIPA, the apoptotic pathway that protects mice from viral Pathogenesis[J]. Immunity. 2016;44(5):1151\u201361.","journal-title":"Immunity"},{"issue":"90","key":"13592_CR20","doi-asserted-by":"publisher","first-page":"eadf4919","DOI":"10.1126\/sciimmunol.adf4919","volume":"8","author":"L WU","year":"2023","unstructured":"WU L, HONG X, YANG C, et al. Noncanonical MAVS signaling restrains dendritic cell-driven antitumor immunity by inhibiting IL-12[J]. Sci Immunol. 2023;8(90):eadf4919.","journal-title":"Sci Immunol"},{"issue":"1","key":"13592_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cmi.2016.25","volume":"14","author":"YANB MAYER-BARBER K D","year":"2017","unstructured":"MAYER-BARBER K D YANB. Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses[J]. Cell Mol Immunol. 2017;14(1):22\u201335.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"13592_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41597-023-02257-1","volume":"10","author":"Z LI","year":"2023","unstructured":"LI Z, ZHANG H, LI Q, et al. GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases[J]. Sci Data. 2023;10(1):376.","journal-title":"Sci Data"},{"issue":"3","key":"13592_CR23","first-page":"100141","volume":"2","author":"T WU","year":"2021","unstructured":"WU T, HU E, XU S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data[J]. Innov (Camb). 2021;2(3):100141.","journal-title":"Innov (Camb)"},{"issue":"1","key":"13592_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S JIN","year":"2021","unstructured":"JIN S, GUERRERO-JUAREZ C F, ZHANG L, et al. Inference and analysis of cell-cell communication using CellChat[J]. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"key":"13592_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41523-018-0088-0","volume":"4","author":"B YANG","year":"2018","unstructured":"YANG B, CHOU J, TAO Y, et al. An assessment of prognostic immunity markers in breast cancer[J]. NPJ Breast Cancer. 2018;4:35.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"13592_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"ARAND HU","year":"2017","unstructured":"HU ARAND, BUTTE A J Z. xCell: digitally portraying the tissue cellular heterogeneity landscape[J]. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"issue":"2","key":"13592_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7150\/ijbs.54074","volume":"17","author":"D WEI","year":"2021","unstructured":"WEI D, RUI B, QINGQUAN F, et al. KIF11 promotes cell proliferation via ERBB2\/PI3K\/AKT signaling pathway in gallbladder cancer[J]. Int J Biol Sci. 2021;17(2):514\u201326.","journal-title":"Int J Biol Sci"},{"key":"13592_CR28","doi-asserted-by":"publisher","first-page":"100960","DOI":"10.1016\/j.drup.2023.100960","volume":"68","author":"R QI","year":"2023","unstructured":"QI R, BAI Y, LI K, et al. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs[J]. Drug Resist Updat. 2023;68:100960.","journal-title":"Drug Resist Updat"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13592-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13592-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13592-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T11:25:02Z","timestamp":1738581902000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13592-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13592"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13592-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved and supported by the Ethics Committee of the Fudan University (2023\u2009\u2212\u2009170) and performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}